Shares of Codexis Inc. (CDXS) are currently trading at a significant discount compared to their 52-week high of $6.08, recorded in December of last year, with the stock now priced around $3.
Codexis is a biotechnology company specializing in enzymatic solutions designed to enable efficient and scalable production of complex therapeutics through its proprietary CodeEvolver technology platform. The company operates across two core segments - Pharma Biocatalysis and Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis manufacturing platform.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.